Updated Alcohol Abuse Guidelines

CEimpact Podcast

Alcohol Use Disorder (AUD) and cirrhosis are common medical conditions with significant morbidity and mortality. Join host, Geoff Wall, as he evaluates the new American College of Gastroenterology guidelines.
The GameChanger
The MELD score is now preferred over the Madrey score for assessing mortality. Baclofen is the primary treatment for reducing consumption and craving in alcohol use disorder.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, Shah VH. ACG Clinical Guideline: Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1. PMID: 38174913.
https://journals.lww.com/ajg/fulltext/2024/01000/acg_clinical_guideline__alcohol_associated_liver.13.aspx?context=featuredarticles&collectionid=5

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the initial treatment of a patient admitted with acute alcoholic hepatitis
2. Describe a pharmacotherapeutic plan for adjunctive treatment of alcohol use disorder
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-042-H01-P
Initial release date: 1/22/2024
Expiration date: 1/22/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Chapter

1. Updated Alcohol Abuse Guidelines (00:00:00)

2. New Guidelines on Alcohol Use Disorder (00:00:08)

3. Treatment Recommendations for Alcohol Withdrawal (00:15:09)

4. Treating Alcoholic Hepatitis and Abandoning Score (00:19:38)